WHO Nicotine Pouch Report Sparks Backlash as Experts Highlight Safer Alternatives Are Being Ignored

The latest report from the World Health Organisation on nicotine pouches has stirred more debates about tobacco harm reduction, especially among experts in the field. There’s a lot of disagreement among global regulators about how to approach these safer nicotine products. The report, named “Exposing Marketing Tactics and Strategies Driving the Growth of Nicotine Pouches,” claims that manufacturers are playing fast and loose with regulations while targeting young people with their marketing. But here’s the kicker: many researchers feel the report misses a crucial point. For millions of adult smokers, smoke-free nicotine options could be their best shot at kicking the habit of traditional cigarettes.

Cigarette smoking is still the leading preventable cause of death around the globe, claiming more than seven million lives each year. And then there’s the undeniably promising data from countries endorsing the use of safer nicotine alternatives like vaping devices, heated tobacco products, snus, and nicotine pouches, proving that they can really help cut down smoking rates when adults have access to them.

The WHO report comes out just as discussions about harm reduction are heating up. In the US, a lot of the media chatter surrounding former FDA Commissioner Marty Makary’s resignation has focused on supposed political pressure and lobbying over flavoured vape approvals. Yet, what’s often overlooked is the scientific angle: youth vaping rates have taken a nosedive, and smoking rates for both young folks and adults are at all-time lows.

This points to a bigger problem in today’s nicotine policy discussions. Sensationalist headlines often overshadow the public health evidence that should guide decisions. Some researchers have spoken out about the WHO pouch report. Dr Jamie Hartmann-Boyce from the University of Massachusetts Amherst noted that while we still need to learn more about the long-term effects of nicotine pouches, there is already strong evidence that safer alternatives help smokers quit traditional cigarettes. The real issue behind smoking-related cancers is not nicotine itself, but the burning of tobacco. This difference is key to understanding tobacco harm reduction.

Even some former WHO officials are now questioning why the organisation resists harm reduction strategies. In a recent article in Nature Health, former directors Robert Beaglehole, Ruth Bonita, and Tikki Pang argued that the world cannot reach the goal of reducing smoking rates below 5 per cent by 2040 without including safer nicotine products in tobacco control plans.

Their criticism was clear and direct. They explained that many policymakers still mix up nicotine use with the diseases caused by smoking, even though decades of research show that smoke, not nicotine, is what leads to tobacco-related deaths. They also warned that the WHO’s Framework Convention on Tobacco Control has focused too much on taxes and advertising restrictions, while ignoring harm-reduction approaches.

There are some pretty clear examples out there that back up these worries. Take Japan, for instance—once heated tobacco products hit the scene, cigarette sales took a nosedive. Then there’s New Zealand, where smoking rates really started to plummet after vaping options popped up in 2018. Sweden’s got a similar story; the only country worldwide which has achieved the much sought-after smoke-free status has achieved the low smoking rates by supporting the use of oral nicotine products for smoking cessation or substitution. And in the UK? Vaping has actually become more popular than smoking among quite a few adult groups.

Professor Caitlin Notley from the University of East Anglia acknowledged that it’s wise to be cautious about claims that nicotine pouches help people quit, since there isn’t much long-term data yet. However, she also noted that new evidence, including her review of over 20,000 online public comments, shows many former smokers found nicotine pouches useful for quitting cigarettes or even vaping.

This idea is becoming more important in global harm reduction policy discussions. Strict measures like flavour bans or high taxes may fit some beliefs about avoiding nicotine, but they could actually make it harder for adults to quit smoking for good. There are plenty of examples; in the Netherlands, a vape flavour ban led to an increase in smoking and black market activity.

To this end, policymakers in Canada are being very cautious about implementing such a ban proposed in recent years; they agree that the evidence is mixed and suggests these bans could lead to more black-market activity and fewer legal vape shops. Many adults also prefer flavoured products when trying to quit smoking. Even researchers who support protecting youth admit that total bans can sometimes have the opposite effect.

Dr Harry Tattan-Birch from University College London stressed that while it’s important to regulate nicotine pouches, rules should be based on their relative risk. Because these pouches don’t involve burning or inhaling tobacco like cigarettes, they are probably much less harmful than regular cigarettes. Banning them completely, while still allowing easy access to cigarettes, could actually harm public health. This opinion reflects wider criticisms now being raised about both WHO and FDA regulations.

The main question isn’t whether smoke-free nicotine products should be regulated—they should. It’s whether regulators will recognise how much safer these options are compared to traditional cigarettes and change their policies to reflect that.

For years, public health efforts have rightly focused on lowering smoking rates. But recently, it seems that some parts of the global tobacco control movement want to get rid of all nicotine use, without weighing the different risks involved. This change could have serious costs.

Countries that support harm reduction see their smoking rates drop faster than those that stick to strict bans. At the same time, illegal markets grow wherever access to safer alternatives is too limited. As Robert Beaglehole recently pointed out, all the evidence suggests that smoke-free nicotine products give us a unique opportunity to fight the smoking epidemic much faster than traditional tobacco control methods alone. The real question now is whether global regulators will listen to this evidence or keep fighting against tools that could help lower smoking rates more quickly.

The US FDA Considers Allowing Some Vape Flavours in Major Regulatory Shift